BioReference Laboratories

108 articles with BioReference Laboratories

• OPKO Health's BioReference Laboratories Launches Multiplex COVID-19 and Influenza A/B Test

  10/20/2020

  BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), is now accepting specimens for a new multiplex COVID-19 and influenza test for use by healthcare providers, clinics and health systems throughout the United States, to aid in the diagnosis of COVID-19 and Influenza A or B (flu).

• OPKO Health's BioReference Laboratories Launches COVID-19 Testing Program for New York City Schools

  10/9/2020

  BioReference Laboratories, Inc., an OPKO Health company (NASDAQ :OPK), today announced the beginning of its COVID-19 testing program for New York City schools throughout the 2020-2021 school year to help ensure a safer school environment.

• OPKO Health's BioReference Laboratories Announces New York City Schools COVID-19 Testing Program

  9/2/2020

  The COVID-19 testing program will test principals, teachers and staff in preparation for a safer back-to-school environment

• OPKO Health's BioReference Laboratories Launches Best-in-Class Next-Generation Sequencing (NGS) Assay

  9/1/2020

  BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), along with its specialty oncology division, GenPath, today announced the launch of OnkoSight AdvancedTM, a next-generation sequencing (NGS) assay that enables revolutionary deoxyribonucleic acid (DNA) mutational profiling of tumor samples.

• OPKO Health's GeneDx Adds GenomeXpress to Its Industry-Leading Clinical Genomics Portfolio

  8/6/2020

  GeneDx, Inc., a subsidiary of BioReference Laboratories, Inc., an OPKO Health company, announced the launch of GenomeXpress, a rapid genome sequencing test.

• Geoff Monk, President of OPKO Health's BioReference Laboratories, Named to CEO Today's Healthcare 2020 Awards List

  7/21/2020

  BioReference Laboratories, Inc., an OPKO Health company, announced that Geoff Monk, President of BioReference Laboratories, was recognized by CEO Today Magazine as one of this year's 20 Healthcare Award winners.

• OPKO Health's BioReference Laboratories Awarded Commercial Surge Capacity Testing for COVID-19 Emergency Response Contract by Centers for Disease Control and Prevention (CDC)

  7/20/2020

   BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced it will accept an Indefinite Delivery Indefinite Quantity (IDIQ) contract award to provide Commercial Surge Capacity Testing for COVID-19 Emergency Response to the Centers for Disease Control and Prevention (CDC).

• OPKO Health's BioReference Laboratories to Provide COVID-19 Testing for National Basketball Association Players and Employees

  7/13/2020

  BioReference initiates COVID-19 testing for all National Basketball Association players and referees, as well as team and league staff for its season restart in Orlando on July 30

• Major League Soccer Chooses OPKO Health's BioReference Laboratories to Provide COVID-19 Testing for Players and Employees

  7/9/2020

   BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), will conduct COVID-19 testing for all Major League Soccer (MLS) players as well as match officials, and Club and League staff participating in the MLS is Back Tournament.

• OPKO Health's BioReference Laboratories Reports Results of COVID-19 Testing for Almost One Quarter of a Million Nursing Home and Live-in Facility Employees

  7/1/2020

  Based on internal data, 29% of nursing home employees tested positive for antibodies Since the beginning of the COVID-19 pandemic, BioReference has performed 222,000 COVID-19 PCR and 3,500 antibody tests in over 350 facilities

• MagnaCare and BioReference Laboratories Bring COVID-19 Antibody Testing to New York Labor Groups

  5/18/2020

  MagnaCare today announced a collaboration with BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), to bring COVID-19 antibody testing to their Labor clients in the New York metropolitan area. Through this collaborati

• OPKO Health's BioReference Laboratories and Westchester Medical Center Health Network Enter Into Strategic Laboratory Collaboration to Deliver Operational and Diagnostic Services

  5/13/2020

  BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced a strategic collaboration with the Westchester Medical Center Health Network (WMCHealth), a 1,700-bed healthcare system headquartered in Valhalla, New York , to provide full laboratory administrative services, laboratory operations, reference t

• OPKO Health's BioReference Laboratories Launches COVID-19 Employer Solution

  5/13/2020

  BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today launched the BioReference Employer Solution, a COVID-19 screening program that assists employers' decisions about return-to-work policies.

• OPKO Health's BioReference Laboratories Launches COVID-19 Antibody Screening for New York City Residents

  5/8/2020

  In partnership with NYC Health + Hospitals, BioReference is expanding access to COVID-19 antibody testing

• OPKO Health's BioReference Laboratories in Partnership with New York State Initiates Testing for COVID-19 Antibodies

  4/29/2020

  BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), announced that beginning today it will offer antibody blood tests to detect an immune response after infection with the COVID-19 virus. Antibody testing and molecular diagnostic testing for COVID-19 are available to healthcare providers nationwide.

• OPKO Health's BioReference Laboratories Partners with Hospitals Nationwide to Provide Prioritized Testing to Inpatients with Suspected Coronavirus Disease 2019 (COVID-19)

  4/6/2020

  BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced that it will continue to prioritize COVID-19 testing for hospital inpatients and critically ill patients around the country.

• OPKO Health's BioReference Laboratories and City of Miami Provide Testing for Coronavirus Disease 2019 (COVID-19)

  3/24/2020

  BioReference will offer COVID-19 testing for public drive-through facilities for Miami residents and Larkin Community Hospital

• OPKO Health's BioReference Laboratories and City of Detroit Provide Testing for Coronavirus Disease 2019 (COVID-19)

  3/23/2020

  BioReference Laboratories, Inc. announced a collaboration with the City of Detroit to provide coronavirus disease 2019 testing.

• OPKO Health's BioReference Laboratories and State of New Jersey Provide Testing for Coronavirus Disease 2019 (COVID-19)

  3/20/2020

  BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced a collaboration with the State of New Jersey to provide coronavirus disease 2019 (COVID-19) testing across the State

• OPKO Health's BioReference Laboratories and NYC Health + Hospitals Enter into Laboratory Collaboration to Provide Testing for Coronavirus Disease 2019 (COVID-19)

  3/17/2020

  BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced a collaboration with the New York City Health and Hospital Corporation (NYC Health + Hospitals) to provide coronavirus disease 2019 (COVID-19) testing